Lincoln Pharmaceuticals Limited (NSE:LINCOLN)
593.20
-6.55 (-1.09%)
Apr 25, 2025, 3:29 PM IST
Lincoln Pharmaceuticals Revenue
Lincoln Pharmaceuticals had revenue of 1.47B INR in the quarter ending December 31, 2024, with 0.07% growth. This brings the company's revenue in the last twelve months to 5.98B, up 8.54% year-over-year. In the fiscal year ending March 31, 2024, Lincoln Pharmaceuticals had annual revenue of 5.81B with 13.76% growth.
Revenue (ttm)
5.98B
Revenue Growth
+8.54%
P/S Ratio
1.98
Revenue / Employee
3.54M
Employees
1,687
Market Cap
11.85B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2024 | 5.81B | 702.41M | 13.76% |
Mar 31, 2023 | 5.10B | 381.86M | 8.09% |
Mar 31, 2022 | 4.72B | 479.38M | 11.30% |
Mar 31, 2021 | 4.24B | 376.95M | 9.75% |
Mar 31, 2020 | 3.86B | 203.44M | 5.56% |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Mar 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Sun Pharmaceutical Industries | 516.03B |
Divi's Laboratories | 90.78B |
Cipla | 267.20B |
Mankind Pharma | 116.41B |
Apollo Hospitals Enterprise | 211.46B |
Zydus Lifesciences | 222.47B |
Aurobindo Pharma | 309.22B |
Alkem Laboratories | 127.57B |